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To the editor: We applaud the successful implemen-
tation of meticillin-resistant Staphylococcus aureus 
(MRSA) screening programme on the German side of 
the Dutch–German border region (EUREGIO) [1]. The 
described strategy is based on the risk-based admis-
sion screening approach [1]. 
From our experience with ‘search and destroy’ (S and 
D) in the Netherlands, we learned that it is essential to 
evaluate and timely enlarge risk categories when epi-
demiology changes to prevent MRSA of unknown ori-
gin (MUO), i.e. not fitting any defined risk factors [2]. 
Herewith, we report our recent finding of a previously 
unrecognised risk group for MRSA: seafarers. 
In 2010, we noticed that clinical cultures with unex-
pected MRSA in the Harbour Hospital (Port of 
Rotterdam, the Netherlands) were mainly from sea-
farers. Although the Harbour Hospital is especially 
equipped for seafarers, this patient population only 
accounts for 1.2% of all admissions [3]. Since seafar-
ers are not considered an MRSA risk group, all sea-
farer patients were screened (nose and throat) at the 
Emergency Department of the Harbour Hospital in a six 
month prospective surveillance (2011). Perineum and 
wounds were screened additionally, if active infection 
or skin lesions were present. Detection of MRSA was 
performed as previously described [4], and spa typing 
was done at the reference laboratory of the National 
Institute for Public Health and the Environment (RIVM) 
[5]. Furthermore, since the hospital is visited by a 
large number of seafarers, a case–control study was 
designed to identify risk factors for MRSA carriage 
among seafarers, in order to identify specific risk fac-
tors within this putative new risk group. 
Cases were defined as seafarers with a positive MRSA 
culture of any site, whereas controls had a negative 
MRSA culture. Data on demographics, medical history, 
laboratory and naval parameters were collected retro-
spectively. Data were then analysed by univariate (chi-
squared, Fisher’s exact test) and multivariate analysis 
(logistic regression model).
In the study period 124 seafarers (men, 22–51 years 
of age) were included. Four seafarer patients had 
an unknown MRSA status and were excluded. MRSA 
prevalence among seafarers was 5.8% (95% confi-
dence interval (CI): 4.6–7.1) and the incidence rate was 
24.8/1,000 seafarer population. Seven MRSA-positive 
seafarers were identified as cases, leaving 113 MRSA-
negative seafarers as controls. Of seven MRSA carriers, 
four had wounds, of which three were cultured MRSA 
positive as well. Furthermore, of seven MRSA strains, 
five had similar spa repeat successions: t019 (twice), 
t122, t975 and t4557. The remaining two were t4845 
and t9231. Nationality was only known for 32 seafarers. 
Table 
Risk factors for meticillin-resistant Staphylococcus aureus 
(MRSA) in seafarers, Rotterdam, the Netherlands
Risk factor
MRSA 
positive
(N=7)
n(%)
MRSA 
negative
(N=113)
n(%)
P-value Odds ratio (95% CI)
Male sex 7 (100) 112 (99) – –
Specialist involved with patient
Internal medicine 2 (29) 21 (19) 0.61 –
Surgery 5 (71) 59 (52) 0.45 –
Physical examination
Presence of 
wounds or 
abscesses
4 (57) 5 (4) <0.01 40.8 (5.9–278.3)
Pus detected 2 (28) 2 (2) 0.01 26.7 (2.9–241.3)
CI: confidence interval; OR: odds ratio.
Presence of wounds or abscesses was the only risk factor (p<0.01) 
in univariate analysis and in the multiple regression model with 
an OR of 40.8 (95%CI: 5.9–278.3). The multiple regression model 
was based on forward selection with ‘presence of wounds or 
abscesses’, ‘detection of pus’ and ‘C-reactive protein (CRP)’ (area 
under the receiver operator characteristic criterion (AUC): 0.75, 
R2max: 0.4603).
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Twenty-five of them were of Asian origin, with 18 sea-
farers from the Philippines. Of MRSA carriers, national-
ity was known in two cases: the Philippines and India. 
Severe missing data for many proposed variables 
forced us to exclude many variables, as registration of 
seafarers was basic due to swift departure and com-
munication difficulties. The remaining risk factors are 
listed in the Table. Presence of wounds or abscesses 
was the only significant risk factor (p<0.01) in both uni-
variate analysis and multivariate regression analysis 
(odds ratio (OR): 40.8 (95% CI: 5.9–278.3)). The multi-
variate regression model was based on forward selec-
tion with ‘presence of wounds or abscesses’, ‘detection 
of pus’ and ‘C-reactive protein (CRP)’ (area under the 
receiver operator characteristic criterion (AUC): 0.75, 
R2max: 0.4603). The positive predictive value for find-
ing an MRSA carrier when a seafarer had a wound was 
44% whereas the negative predictive value (MRSA car-
rier when a seafarer has no wound) was 2%. The MRSA 
carriage did not influence the duration of hospitalisa-
tion of the seafarers (p=0.36).
In our limited sample of 124 seafarers, the 5.8% MRSA 
prevalence detected is 52-times higher than the normal 
prevalence in the Netherlands (0.11% at hospital admis-
sion) [4], and the presence of wounds or abscesses 
gave a 40-times higher risk of being MRSA positive. 
Some bias might play a role due to our screening pro-
cedure. However, this choice was made due to commu-
nication difficulties and cultural differences. 
Given the high prevalence rate of carriage among sea-
farers, we recommend that all seafarers should be 
screened for MRSA in the Netherlands, regardless of 
wounds or underlying disease, and to apply pre-emp-
tive isolation while awaiting test results, and should 
be taken into consideration as risk group by other 
European nations. Further studies are necessary to 
understand the impact of global transmission of MRSA 
clones by seafarers.
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